Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve.
about
Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital MucosaModeling HIV vaccine trials of the future.Some extensions in continuous models for immunological correlates of protection.Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.Reply to Dunning.Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) VaccinationExtensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.Augmented trial designs for evaluation of principal surrogates.Validation and evaluation of serological correlates of protection for inactivated enterovirus 71 vaccine in children aged 6-35 months.Serum vitamin D levels are positively associated with varicella zoster immunity in chronic dialysis patients.Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling.The herpes zoster subunit vaccine.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.Early life socioeconomic position and immune response to persistent infections among elderly LatinosVaccine profile of herpes zoster (HZ/su) subunit vaccine.T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences.Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial.Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials.Correlates of Protection for Herpes Zoster Vaccine: Evaluating Candidate Immunological Variables.A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infectionLive Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women
P2860
Q27347896-48B9ACEC-FC76-4DC2-9726-6E4B40275349Q30393307-E42A58A5-AB63-44D8-BE75-6181E13237B5Q35878996-A47F32CA-BEFE-4178-A7AA-A21B324E63CEQ36024466-2E539A59-548A-4F63-A996-8FFEFA631294Q36181418-B8D45485-16F9-488D-9A33-124152C73846Q36237622-6D9A3055-5BD7-42E7-A22E-58136C93991DQ36601101-467C7DC9-CDAD-4396-96C8-FF88C1ECA9BBQ37025729-260CE442-CC64-4136-940E-23F2524BF3CCQ37130739-3AA6F706-C871-40B6-BFE3-36C3C603F0BEQ37734398-3A1CEE04-96B8-44F6-95CA-2EE029ED0ADCQ38707640-D459C6C2-0E51-40FA-B845-26F8FD8DB11FQ38728931-60A4569A-80F9-43A0-9087-4172B60DFB5FQ39108779-340C6F3A-7806-4A56-84A1-63BA5B569F48Q39471391-7A16B186-20D1-43E6-8A32-23B73253EDA7Q40208840-344A73D2-8ADB-4DF1-A2D7-96D04B761CB5Q40442389-44881D6D-19DF-49DD-B76F-B3205E1A55E1Q41241086-739D9AC1-2609-42AC-9CD0-7FC3A7166F5DQ41926056-70C9C273-70EE-4438-8869-7A419EF74F1FQ46296261-FA4FA022-F9EA-442E-A03B-5957866415DBQ51018900-03BBBDC2-2DAD-4079-A099-089FDE655231Q57072187-A7405E7E-47FB-448B-A139-52661D7899A5Q58426818-7ACCB17B-0979-4271-877A-B8E65BDE8130
P2860
Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Fold rise in antibody titers b ...... ia the vaccine efficacy curve.
@ast
Fold rise in antibody titers b ...... ia the vaccine efficacy curve.
@en
Fold rise in antibody titers b ...... ia the vaccine efficacy curve.
@nl
type
label
Fold rise in antibody titers b ...... ia the vaccine efficacy curve.
@ast
Fold rise in antibody titers b ...... ia the vaccine efficacy curve.
@en
Fold rise in antibody titers b ...... ia the vaccine efficacy curve.
@nl
prefLabel
Fold rise in antibody titers b ...... ia the vaccine efficacy curve.
@ast
Fold rise in antibody titers b ...... ia the vaccine efficacy curve.
@en
Fold rise in antibody titers b ...... ia the vaccine efficacy curve.
@nl
P2093
P2860
P356
P1476
Fold rise in antibody titers b ...... via the vaccine efficacy curve
@en
P2093
Ivan S F Chan
Janie Parrino
Peter B Gilbert
Shu-Chih Su
Xiaoming Li
Xiaopeng Miao
P2860
P304
P356
10.1093/INFDIS/JIU279
P407
P50
P577
2014-05-13T00:00:00Z